c-LEcta GmbH
Alexandra Rockstroh is currently serving as an Intellectual Property Manager and previously held the position of Intellectual Property Associate at c-LEcta GmbH since August 2022. Prior to this role, Alexandra worked at Fraunhofer IZI from 2013 to July 2022, initially as a PhD Candidate and later as a Postdoctoral Researcher, focusing on infectious diseases and contributing to the development of serological diagnostics, vaccine design, and antiviral strategies for various Flaviviruses and SARS-COV-2. Alexandra's educational background includes a Dr. rer. nat. in Virology from Leipzig University, a Master of Science in Pharma Biotechnologie from Fachhochschule Jena, and a Bachelor of Engineering in Biotechnology from the same institution. Further education includes a recent program at Berlin University of Applied Sciences Berlin (BHT).
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.